Medpace Holdings Share Holder Equity 2014-2023 | MEDP

Medpace Holdings share holder equity from 2014 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
  • Medpace Holdings share holder equity for the quarter ending December 31, 2023 was $0.559B, a 44.66% increase year-over-year.
  • Medpace Holdings share holder equity for 2023 was $0.559B, a 44.66% increase from 2022.
  • Medpace Holdings share holder equity for 2022 was $0.386B, a 59.45% decline from 2021.
  • Medpace Holdings share holder equity for 2021 was $0.953B, a 18.26% increase from 2020.
Medpace Holdings Annual Share Holder Equity
(Millions of US $)
2023 $559
2022 $386
2021 $953
2020 $806
2019 $726
2018 $590
2017 $504
2016 $611
2015 $413
2014 $402
2013 $0
Medpace Holdings Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $559
2023-09-30 $471
2023-06-30 $391
2023-03-31 $347
2022-12-31 $386
2022-09-30 $350
2022-06-30 $283
2022-03-31 $605
2021-12-31 $953
2021-09-30 $898
2021-06-30 $852
2021-03-31 $859
2020-12-31 $806
2020-09-30 $792
2020-06-30 $738
2020-03-31 $718
2019-12-31 $726
2019-09-30 $692
2019-06-30 $658
2019-03-31 $622
2018-12-31 $590
2018-09-30 $561
2018-06-30 $540
2018-03-31 $511
2017-12-31 $504
2017-09-30 $550
2017-06-30 $607
2017-03-31 $621
2016-12-31 $611
2016-09-30 $611
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2014-12-31 $402
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $12.163B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $122.475B 15.37
Cencora (COR) United States $44.674B 17.41
ICON (ICLR) Ireland $25.493B 24.07
DiDi Global (DIDIY) China $24.448B 0.00
Avantor (AVTR) United States $16.791B 24.72
Viatris (VTRS) United States $14.026B 4.03
CochLear (CHEOY) Australia $13.917B 0.00
Revvity (RVTY) United States $12.428B 21.78
Charles River Laboratories (CRL) United States $12.026B 21.92
Natera (NTRA) United States $11.711B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $11.540B 0.00
Solventum (SOLV) United States $11.153B 0.00
Sonic Healthcare (SKHHY) Australia $8.297B 0.00
HealthEquity (HQY) United States $6.740B 50.35
Organon (OGN) United States $5.043B 4.78
Bausch + Lomb (BLCO) Canada $4.779B 19.15
Doximity (DOCS) United States $4.494B 33.46
PACS (PACS) United States $3.725B 0.00
Sotera Health (SHC) United States $3.119B 15.31
Surgery Partners (SGRY) United States $3.118B 28.86
Progyny (PGNY) United States $3.049B 51.16
GoodRx Holdings (GDRX) United States $2.804B 142.00
Life Times (LTH) United States $2.783B 29.48
Premier (PINC) United States $2.460B 9.00
AMN Healthcare Services Inc (AMN) United States $2.256B 7.30
Teladoc Health (TDOC) United States $2.167B 0.00
Agilon Health (AGL) United States $1.985B 0.00
BrightSpring Health Services (BTSG) United States $1.969B 0.00
NovoCure (NVCR) Jersey $1.590B 0.00
Establishment Labs Holdings (ESTA) $1.451B 0.00
Agiliti (AGTI) United States $1.374B 22.44
Alignment Healthcare (ALHC) United States $1.264B 0.00
Pediatrix Medical (MD) United States $0.784B 8.11
Embecta (EMBC) United States $0.584B 3.86
InnovAge Holding (INNV) United States $0.549B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.528B 0.00
GeneDx Holdings (WGS) United States $0.512B 0.00
LifeMD (LFMD) United States $0.512B 0.00
Enhabit (EHAB) United States $0.511B 46.27
CareDx (CDNA) United States $0.503B 0.00
Auna S.A (AUNA) Luxembourg $0.480B 0.00
Sonida Senior Living (SNDA) United States $0.463B 0.00
MultiPlan (MPLN) United States $0.422B 0.00
Beauty Health (SKIN) United States $0.415B 0.00
ModivCare (MODV) United States $0.383B 7.18
DocGo (DCGO) United States $0.376B 60.17
Sera Prognostics (SERA) United States $0.352B 0.00
Sharecare (SHCR) United States $0.270B 0.00
Ascend Wellness Holdings (AAWH) United States $0.265B 0.00
Biodesix (BDSX) United States $0.161B 0.00
So-Young (SY) China $0.128B 43.00
Oncology Institute (TOI) United States $0.080B 0.00
Pono Capital Two (PTWO) United States $0.075B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
NeueHealth (NEUE) United States $0.051B 0.00
Co-Diagnostics (CODX) United States $0.038B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
SeaStar Medical Holding (ICU) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
OncoCyte (OCX) United States $0.022B 0.00
DermTech (DMTK) United States $0.022B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.013B 0.00
BIMI Holdings (BIMI) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
OpGen (OPGN) United States $0.006B 0.00
NewGenIvf Group (NIVF) Singapore $0.005B 0.00
Assure Holdings (IONM) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00